INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SL
Schupmann LaurieDirector
STSensata Technologies Holding plc
Grant or award
A—
3,827 sh
Jun 9, 2026Jun 11, 2026
Page 699 of 1737
← PrevNext →
traded Jun 9, 2026
+2d
SEC Form 4

Evidence

9
BS
Black Michael ScottChief Revenue Officer
BARKBark, Inc.
Tax withholding
F$1,580
156 sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

9
KA
Kidder Todd A.Director, CHAIRMAN OF THE BOARD
CLSTCatalyst Bancorp, Inc.
Grant or award
A—
2,645 sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

9
BD
Bellard Ted D.Director, SECRETARY
CLSTCatalyst Bancorp, Inc.
Grant or award
A—
2,645 sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

9
TW
Thomas WendyDirector
MQMarqeta, Inc.
Option exercise
M—
36.3K sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

9
SN
Shah NirajDirector
NXDRNextdoor Holdings, Inc.
Grant or award
A—
85.4K sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

9
BW
Bonifant William W.GVP, Chief Supply Chain Ofc.
HRLHORMEL FOODS CORP /DE/
Grant or award
A—
34.9K sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

9
RJ
Rocchio Betty JoDirector
TELATELA Bio, Inc.
Grant or award
A—
17.3K sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

8
SK
Subaiya Thimaya K.EVP, Operations
CSCOCISCO SYSTEMS, INC.
Tax withholding
F$206K
1,715 sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

8
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$45K
8,500 sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

6
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
2,462 sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

6
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$36K
7,289 sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
MJ
Mirshekari Ali JohnDirector
STSensata Technologies Holding plc
Tax withholding
F$22K
439 sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

5
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
68.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
GM
Gray Jonice MDirector
VACMARRIOTT VACATIONS WORLDWIDE Corp
Grant or award
A—
118 sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
AN
Atkinson NajumaDirector
MQMarqeta, Inc.
Grant or award
A—
52.2K sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
PB
Piekos BrianChief Financial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
21.7K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
CM
Cummings MarthaDirector
MQMarqeta, Inc.
Option exercise
M—
36.3K sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
RJ
Riese Phillip JohnDirector
RELYRemitly Global, Inc.
Option exercise
M—
9,533 sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
FP
Feinberg PeterDirector
IMRXImmuneering Corp
Grant or award
A—
33.4K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
PB
Piekos BrianChief Financial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
55.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
100.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
40.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
SJ
Sweet Alan JeffreyDirector
NKSHNATIONAL BANKSHARES INC
Grant or award
A—
221 sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
PB
Piekos BrianChief Financial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
100.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
25.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
PE
Paul ElaineDirector
MQMarqeta, Inc.
Option exercise
M—
36.3K sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
93.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
150.3K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
93.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
PB
Piekos BrianChief Financial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
93.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
68.8K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
100.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
CM
Cummings MarthaDirector
MQMarqeta, Inc.
Grant or award
A—
52.2K sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
59.3K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
AN
Atkinson NajumaDirector
MQMarqeta, Inc.
Option exercise
M—
36.3K sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
SJ
Schall Thomas J.Director
IMRXImmuneering Corp
Grant or award
A—
33.4K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence

5
PE
Paul ElaineDirector
MQMarqeta, Inc.
Grant or award
A—
52.2K sh
Jun 10, 2026Jun 11, 2026
traded Jun 10, 2026
+1dSEC Form 4

Evidence

5
WG
Wright Robert G.EVP
DKDelek US Holdings, Inc.
Tax withholding
F$48K
1,024 sh
Jun 9, 2026Jun 11, 2026
traded Jun 9, 2026
+2dSEC Form 4

Evidence

5
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Disposition to issuer
D—
40.0K sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC Form 4

Evidence